과학
기타
Availability of generic semaglutide removes barrier to affordable diabetes care, experts predict
Medical Xpress

In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers predict that anticipated price reductions of up to 70% will dramatically increase both the cost-effectiveness and health system affordability of therapy options for patients with type 2 diabetes and high cardiorenal risk. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'science' 카테고리 뉴스
Medical Xpress의 다른 기사
Doctors 'cringe' at possibility of documenting which Medicaid enrollees are too sick to work
Medical Xpress
Women with PMOS at four-fold higher risk of heart disease
Medical Xpress
Latest evidence on risk factors, early intervention, and strategies to prevent heart failure before symptoms develop
Medical Xpress